GALT 241220 15.00P (GALT241220P15000) Stock Options, News & Quotes - Moomoo

Log Out

US OptionsDetailed Quotes

GALT241220P15000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Galectin Therapeutics Presents Clinical Data on NAVIGATE Trial for Esophageal Varices in MASH Cirrhosis at AASLD 2024
Quiver QuantitativeNov 18 08:13 ET
Galectin Therapeutics Presents 3 Abstracts At The American Association For The Study Of Liver Diseases 2024 Liver Meeting
BenzingaNov 18 08:01 ET
Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More
Seeking AlphaNov 18 00:09 ET
H.C. Wainwright Maintains Galectin Therapeutics(GALT.US) With Buy Rating, Maintains Target Price $11
Moomoo NewsNov 15 07:33 ET · Ratings
Optimistic Buy Rating for Galectin Therapeutics: Strategic Trial Design and Financial Stability Boost Prospects
TipRanksNov 15 06:35 ET · Ratings
Galectin Therapeutics Reports Increased Q3 Losses
TipRanksNov 14 23:24 ET

Comments

Oct 3, 2023 07:01

$Galectin Therapeutics (GALT.US)$ news about outcome of fourth data and safety

Mcsnacks H Tupack

Mar 5, 2023 01:40

Last resistance

$Galectin Therapeutics (GALT.US)$ Breakout is at 2.57. That should run it to 4.80 after shorts cover.

6

Nov 2, 2022 20:15

$Galectin Therapeutics (GALT.US)$ going to have presentations from 4 to 8 nov, where they share scientific sharings. will be watching this

2

1

Jan 21, 2022 18:10

$Galectin Therapeutics (GALT.US)$ wake up

Aug 10, 2021 04:36

$Galectin Therapeutics (GALT.US)$ what is going on?

Read more